Investigation of the Clinical Significance and Prognostic Value of the lncRNA ACVR2B-As1 in Liver Cancer

Table 4

Univariate and multivariate analysis of relapse-free survival in patients with liver cancer.

Parameters	Univariate analysis			Multivariate analysis
	Hazard ratio	95%CI (lower∼upper)	value	Hazard ratio	95% CI (lower-upper)	value
Age	0.89	0.63–1.27	0.521
Gender	0.98	0.69–1.4	0.919
Histological type	2.03	0.66–6.29	0.218
Histologic grade	0.98	0.8–1.21	0.873
Stage	1.66	1.38–1.99	≤0.001	1.16	0.9–1.5	0.259
T Classification	1.78	1.49–2.12	≤0.001	1.57	1.2–2.04	0.001
N classification	0.98	0.68–1.42	0.926
M Classification	1.19	0.8–1.78	0.394
Radiation therapy	0.75	0.26–2.17	0.592
Residual tumor	1.27	1.01–1.61	0.042	1.39	1.09–1.76	0.007
ACVR2B-AS1	1.71	1.21–2.41	0.002	1.66	1.17–2.37	0.005